Guffaw
发表于 2025-3-21 16:05:34
书目名称Creating R&D Incentives for Medicines for Neglected Diseases影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0239402<br><br> <br><br>书目名称Creating R&D Incentives for Medicines for Neglected Diseases读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0239402<br><br> <br><br>
fatuity
发表于 2025-3-21 20:40:52
http://reply.papertrans.cn/24/2395/239402/239402_2.png
鄙视读作
发表于 2025-3-22 02:55:32
Legal and Economic Analysis of Parallel Imports,duct faces potential competition from parallel imports by a foreign exclusive distributor. The model suggests that parallel imports will never occur in the sub-game perfect Nash equilibrium, as it will always be beneficial for the manufacturer to monopolize the home country by undercutting the price
Chivalrous
发表于 2025-3-22 06:16:49
Solutions for the Problem of Underinvestment in R&D for Medicines for Neglected Infectious and Tropinfectious and tropical diseases. Furthermore, even if patent protection provided an adequate incentive mechanism to successfully stimulate R&D, there would still remain the problem that patented medicines may not be affordable for large groups of consumers in poor countries.
根除
发表于 2025-3-22 10:24:57
https://doi.org/10.1007/978-3-8349-8323-7Forschung & Entwicklung; Forschung und Entwicklung; Innovation; Medicines; Patente; Patents; R&D
fodlder
发表于 2025-3-22 16:33:01
978-3-8349-1730-0Gabler Verlag | Springer Fachmedien Wiesbaden GmbH, Wiesbaden 2009
fodlder
发表于 2025-3-22 17:50:00
The TRIPS Agreement and Access to Patented Medicines, intellectual property (IP). In particular, the TRIPS Agreement is a result of the negotiations of the Uruguay Round (1986-1994), which finalized the General Agreement on Tariffs and Trade (GATT) by creating the World Trade Organization (WTO) on January 1, 1995.
Subjugate
发表于 2025-3-23 00:50:03
http://reply.papertrans.cn/24/2395/239402/239402_8.png
无能力之人
发表于 2025-3-23 01:35:13
http://reply.papertrans.cn/24/2395/239402/239402_9.png
不遵守
发表于 2025-3-23 05:50:40
http://reply.papertrans.cn/24/2395/239402/239402_10.png